Lv7
5008 积分 2022-09-30 加入
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer
24天前
已完结
A New Standard in Muscle-Invasive Bladder Cancer — The End of the Cisplatin Era?
24天前
已完结
Current best practice for bladder cancer: a narrative review of diagnostics and treatments
4个月前
已完结
Multiparametric MRI‐Based Deep Learning Radiomics Model for Assessing 5‐Year Recurrence Risk in Non‐Muscle Invasive Bladder Cancer
5个月前
已完结
Artificial intelligence in radiology
6个月前
已完结
Automated Midline Shift Detection in Head CT Using Localization and Symmetry Techniques Based on User-Selected Slice
7个月前
已完结
Intratumoral Heterogeneity of Molecular Subtypes in Muscle-invasive Bladder Cancer—An Extensive Multiregional Immunohistochemical Analysis
7个月前
已完结
Overall survival, disease‐specific survival and local recurrence outcomes in patients with muscle‐invasive bladder cancer treated with external beam radiotherapy and brachytherapy: a systematic review
7个月前
已关闭
Repeat TURBT for Ta and T1 bladder cancer: An updated review
8个月前
已完结
Multi-task deep learning based on T2-Weighted Images for predicting Muscular-Invasive Bladder Cancer
9个月前
已完结
皖公网安备34019202002308
